Recurrent gastric neuroendocrine tumors treated with total gastrectomy.

World J Gastroenterol

Myounghwa Jung, Jung-Wook Kim, Jae-Young Jang, Sun Hee Park, Young Woon Chang, Department of Internal Medicine, College of Medicine, Kyung Hee University, Seoul 130-702, South Korea.

Published: December 2015

Gastric neuroendocrine tumors are rare; however, the incidence has recently increased due to the increasing use of upper endoscopy. Neuroendocrine tumors arise from the excess proliferation of enterochromaffin-like (ECL) cells. The proliferative changes of enterochromaffin cells evolve through a hyperplasia-dysplasia-neoplasia sequence that is believed to underlie the pathogenesis of gastric neuroendocrine tumors. Endoscopic resection is recommended as the initial treatment if the tumor is not in an advanced stage. However, there is no definite guideline for the treatment of recurrent gastric neuroendocrine tumors following endoscopic resection. Here, we report a rare case of gastric neuroendocrine tumors in a 56-year-old male who experienced two recurrences within 11 years after endoscopic resection. The patient finally underwent a total gastrectomy. The pathological features of the resected stomach exhibited the full hyperplasia-dysplasia-neoplasia sequence of the ECL cells in a single specimen.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674739PMC
http://dx.doi.org/10.3748/wjg.v21.i46.13195DOI Listing

Publication Analysis

Top Keywords

neuroendocrine tumors
24
gastric neuroendocrine
20
endoscopic resection
12
recurrent gastric
8
total gastrectomy
8
ecl cells
8
hyperplasia-dysplasia-neoplasia sequence
8
tumors endoscopic
8
neuroendocrine
6
tumors
6

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!